Lexaria Bioscience
LEXX
LEXX
12 hedge funds and large institutions have $1.41M invested in Lexaria Bioscience in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $1.85M → $1.41M (-$441K)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$40K | |
| 2 | +$17.7K | |
| 3 | +$9K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.06K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$15 |